Yale scientists traced gamma brain waves to thalamus-cortex interactions. The discovery could reveal how brain rhythms shape perception and disease.
For more than a century, scientists have observed rhythmic waves of synchronized neuronal activity in the brain. Now, for the first time, researchers at Yale University have pinpointed where a specific type of this activity—known as gamma waves—originates and have linked it directly to behavior.
Through the development of a highly precise new method for measuring brain activity, the team overcame long-standing technical barriers that had prevented a clear understanding of how these oscillations contribute to information processing and behavioral control.
The findings were recently published in the journal Nature.
Following an unexpected discovery
Jessica Cardin, PhD, the Gordon M. Shepherd Professor of Neuroscience at Yale School of Medicine and senior author of the study, did not initially plan to revisit this topic. As a postdoctoral researcher, she had previously shown that gamma waves could be artificially induced in the brain, but she considered the "perfect experiment" to test their function nearly impossible.
In neuroscience, determining the role of an element such as a gene, protein, or neural rhythm typically involves disrupting it to observe the consequences. However, that approach does not work for brain oscillations.

That changed when one of her postdoctoral fellows, Quentin Perrenoud, PhD—the study's first author—presented intriguing data he had gathered while tracking how information moved through the brain during a behavioral task. The results suggested that gamma waves might be predicting behavior. Encouraged by the evidence, the team pursued the lead, ultimately uncovering findings that challenge long-held assumptions about how these brain rhythms arise.
"It's not quite a perfect experiment, but it's a lot closer to a perfect experiment than we've ever been able to get," says Cardin.
Gamma activity emerges from interactions between the thalamus and cortex
To carry out the study, the research team created a new, highly detailed method to measure gamma waves. These brain oscillations were once believed to be continuous, resembling the smooth, unbroken rise and fall of a sound wave. However, more recent evidence suggests that gamma activity does not occur in a steady flow but instead appears in short, intermittent bursts.
Building on this concept, the researchers recorded neuronal activity at 16 distinct locations within the visual cortex—the region of the brain responsible for processing visual information. This allowed them to capture both the spatial and temporal dynamics of gamma activity with greater precision. They then separated the recordings into individual gamma events, each representing a single peak-to-trough-to-peak cycle of a wave.
If gamma activity truly behaved like a continuous oscillation, combining all these discrete events would produce a seamless wave pattern moving across the recorded brain regions.
"But it turned out that these events can happen together, or in little bursts, or all by themselves," says Cardin. "They're not happening in a long sequence."
This approach, which the researchers have named CBASS (Clustering Band-limited Activity by State and Spectrotemporal feature), offers a much greater level of sensitivity than other techniques for studying gamma activity.
"It allows us to get very fine timing and to clearly identify these short events, which means we can map them with great precision during interesting moments, like when an animal is making a decision," says Cardin. "That means we can map the events in the brain to the behavior of the animal with more precision than we've ever had before."
When it comes to where gamma activity arises, there have been two schools of thought. A lot of the available evidence has supported the idea that gamma activity is generated in the cortex. But some research has suggested the cortex inherits the activity from elsewhere in the brain—for example, from the thalamus, which sends a lot of sensory and motor information to the cortex.
"With this new method, our data suggest both are wrong, and that this activity arises due to an interaction between the thalamus and the cortex. Gamma arises dynamically as the thalamus sends input to the cortex, where it's then amplified," says Cardin.
Disrupting signals from the thalamus affects behavior
The precision of CBASS also gives the researchers that much-sought-after ability to break the system, to disrupt these patterns of activity in a way that doesn't affect the entire brain.
To do that, the researchers first trained mice on a visual task wherein the mice received a reward if they licked a waterspout only when a certain visual stimulus was shown. Then, the researchers disrupted the signals that the thalamus sent to the cortex, which, in turn, disrupted the gamma activity in the cortex.
This gamma disruption caused the mice to perform much worse on the visual task. So then the researchers took the opposite approach and artificially initiated gamma activity.
"We recorded gamma activity from mice who were detecting the visual stimulus and then played it back into the brain of other mice. And when we did that, it tricked the mice into thinking they had detected a stimulus," says Cardin.
Together, the findings indicate that gamma activity in the cortex supports the integration of visual information and is involved in the behavioral responses that emerge from that integration. And this is important information to have, as studies have shown that this type of activity is altered in people with neurodevelopmental disorders, schizophrenia, and bipolar disorder, as well as neurodegenerative diseases.
Future directions: linking gamma activity to disease and cognition
Cardin's lab is now looking into whether gamma activity in the cortex could be used as an early biomarker for conditions like Alzheimer's disease. Acetylcholine and norepinephrine, key signaling molecules in the thalamus and cortex, are tightly linked to cognition and lost in neurodegenerative diseases. These neuromodulatory signals are known to regulate the pattern of brain activity.
"We're starting to look at how neuromodulatory signals are associated with these gamma events and we'll apply our tools to better understand the sequence of things that go wrong in neurodegeneration," says Cardin. "This could lead to an interpretable early biomarker for Alzheimer's disease that is easily accessible in humans."
Reference: "Flexible perceptual encoding by discrete gamma events" by Quentin Perrenoud, Antonio H. de O. Fonseca, Austin Airhart, James Bonanno, Rong Mao and Jessica A. Cardin, 8 October 2025, Nature.
DOI: 10.1038/s41586-025-09604-9
The researched reported in this news article was supported by the National Institutes of Health (awards EY022951, EY035127, MH113852, and EY026878) and Yale University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Additional support was provided by the McKnight Foundation, the Kavli Institute of Neuroscience, and the Brain and Behavior Research Foundation.
News
China makes early progress in using sound waves to stimulate damaged brains
Chinese researchers are testing whether focused ultrasound can help restore consciousness in patients with severe brain injuries, adding to a growing international effort to use sound waves to stimulate deep brain structures without surgery. [...]
Micro-drones fly through the body thanks to ultrasound
At the EPFL, micro-drones have been developed that can be moved without a motor or battery.No motors, no batteries, no electronics on board, just small cavities that convert sound waves into thrust: this is [...]
A Single Enzyme Could Hold the Key to Treating a Devastating Brain Disorder
Blocking an enzyme’s production restored brain growth and healthy behaviors in mice engineered to develop Angelman syndrome, pointing to a possible treatment target. Children with Angelman syndrome begin to show difficulties with thinking and [...]
Scientists Develop a Clever New Way To Kill Cancer Cells From the Inside
Scientists have developed an experimental strategy that exploits a chemical byproduct of cancer cells to produce anticancer drugs directly inside them. Scientists in Japan have developed an experimental method that uses a chemical produced [...]
Our books are available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
After only a short training, people in a coma managed to send targeted signals
Researchers have succeeded in communicating with brain-injured patients who are unconscious. They see enormous potential in this for future treatments. Patients who lie motionless in bed after a severe brain injury and do not [...]
MIT Scientists Reprogram Immune Cells Inside the Body To Destroy Cancer
Natural killer cells reprogrammed inside mice eliminated lymphoma tumors and helped damaged livers heal, though whether this approach could help people with cancer or autoimmune disease remains unknown. To make a cancer treatment from [...]
Melanoma mRNA Vaccine Shows Promise in Preventing Disease Recurrence
Key takeaways: Phase 3 trial finds personalized intismeran plus pembrolizumab may better prevent high-risk melanoma recurrence after surgery The trial enrolled 1,137 patients and builds on phase 2 results showing about half the recurrence [...]
Scientists Discover a Powerful New Weapon Against a Dangerous Gut Infection
The promise of an experimental treatment for C. difficile gut infections lies partly in the bacteria it leaves alive, according to early laboratory and mouse research. Broad-spectrum antibiotics can disrupt the gut’s microbial community, [...]
Your Bones May Hold a Hidden Clue to Blood Cancer Survival
For people with blood cancers called myelodysplastic syndromes, osteoporosis may hold an overlooked clue to survival, a three-year observational study suggests. In blood cancers that develop in the bone marrow, an important clue to [...]
Researchers Discover What Reading for Pleasure May Be Doing to Your Brain
Reading for pleasure may offer surprising benefits for the brain, with research linking the habit to better mental health, stronger cognitive abilities, and a lower risk of dementia. Reading for pleasure may do far [...]
Scientists Discover a Hidden Trigger That Keeps Inflammation Alive
Inflammation persists after proteins detach from immune receptors, revealing a potential target for autoimmune treatments. Since a Nobel Prize-winning discovery in the 1990s identified molecules called Toll-like Receptors as the guardians of the human [...]
A Virus Gives Itself Away the Moment It Attacks
Researchers have found the trigger behind a powerful bacterial defense against viruses. Viruses that prey on bacteria could become an increasingly important tool for treating bacterial infections, particularly as antibiotic resistance makes some infections [...]
Scientists Discover Aspirin May Slash Dementia Risk by 70% – but Only for Certain People
Aspirin was linked to a sharply lower dementia risk in some older adults, and their genes may hold the clue. A Monash University analysis found that older adults with a particular genetic profile had [...]
Inflammation May Awaken Dormant Cancer Cells Years After Treatment
The body’s response to inflammation may disturb cancer cells that have been lying silent for years, giving them an opportunity to grow again. Researchers at the Francis Crick Institute have found that gut inflammation [...]
Where do nanoparticles go once they enter the body?
New international best practice guidance, co-written at ANSTO, sets out how to measure where nanoparticles like titanium dioxide end up in the body and how long they remain. The guidance has been shared by [...]















